[Objective evaluation of the therapeutic effect of Coroverlan].
D000368:Aged; D001224:Aspartic Acid / Q000031:analogs & derivatives*; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006331:Heart Diseases / Q000188:drug therapy*; D006801:Humans; D008297:Male; D010936:Plant Extracts / Q000627:therapeutic use*; D011195:Potassium Magnesium Aspartate / Q000627:therapeutic use*; D013806:Theophylline / Q000031:analogs & derivatives* / Q000627:therapeutic use
D004338:Drug Combinations; D010936:Plant Extracts; D001224:Aspartic Acid; D011195:Potassium Magnesium Aspartate; D013806:Theophylline
Zur Objektivierung der therapeutischen Wirkung von Coroverlan.